Market Analysis and Price Projections for the Drug NDC: 61269-0164
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code[1][5].
Identifying the Drug
The NDC 61269-0164 is a specific identifier that corresponds to a particular drug product. However, the provided sources do not directly mention this NDC. To proceed, we need to identify the drug associated with this NDC.
Drug Listing and NDC Directory
The FDA's National Drug Code Directory contains information on active and certified finished and unfinished drugs, including prescription and over-the-counter drugs. The directory is updated daily and includes product listing data submitted by labelers, which can be manufacturers, repackagers, or relabelers[1].
Market Analysis
General Market Trends
The pharmaceutical market, particularly the biopharma and biotech sectors, is experiencing significant growth driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market size was estimated to be over $400 billion in 2024, with a projected compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].
Specific Drug Markets
For drugs like those in the non-small cell lung cancer (NSCLC) market, there is a notable increase in sales driven by premium-priced immune checkpoint inhibitor immunotherapies and targeted therapies. For example, immunotherapies such as Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025, with collective sales of $17.5 billion[4].
Price Projections
Pricing Factors
Drug prices are influenced by several factors, including production costs, market demand, regulatory approvals, and competition. For instance, the prices of drugs like those in the NSCLC market are expected to rise due to the increasing adoption of premium-priced therapies. However, patent expirations can lead to a decline in sales for specific drugs as generics enter the market[4].
Example Pricing
To illustrate how pricing works, consider the example of Tagrisso (osimertinib), a targeted therapy in the NSCLC market. Tagrisso is projected to achieve blockbuster status by 2025 with estimated sales of $1.7 billion, driven by its uptake in the second-line and eventually first-line settings for EGFR-mutant patients[4].
Price Projections for NDC 61269-0164
Without specific details on the drug associated with NDC 61269-0164, it is challenging to provide precise price projections. However, here are some general steps to consider:
- Identify the Drug: Determine the name, strength, and dosage form of the drug associated with the NDC.
- Market Segment: Understand the market segment in which the drug operates. Is it a prescription drug, OTC, or an insulin product?
- Competitive Landscape: Analyze the competitive landscape, including other drugs in the same therapeutic class.
- Regulatory Status: Check if the drug has any recent regulatory approvals or changes that could impact pricing.
- Historical Pricing Data: Review historical pricing data for similar drugs or the same drug if available.
Example Pricing Data
For illustrative purposes, let's consider a hypothetical scenario where the drug associated with NDC 61269-0164 is a prescription medication used in a moderately competitive market.
- Current Price: If the current price of the drug is around $50 per unit, based on market trends and the absence of significant competition or regulatory changes, the price might remain stable or see a moderate increase.
- Future Projections: Assuming a moderate growth rate similar to the overall biopharma market, the price could increase by 5-10% annually over the next few years.
Key Takeaways
- NDC Importance: The NDC is crucial for identifying and tracking drug products.
- Market Trends: The biopharma and biotech markets are growing rapidly, driven by technological advancements and evolving regulatory frameworks.
- Pricing Factors: Drug prices are influenced by production costs, market demand, regulatory approvals, and competition.
- Specific Projections: Without specific details on the drug, precise price projections are challenging, but general market trends can provide a framework for analysis.
FAQs
Q: What is the National Drug Code (NDC)?
A: The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs, including the labeler code, product code, and package code[1][5].
Q: How is the NDC Directory updated?
A: The FDA's National Drug Code Directory is updated daily and includes product listing data submitted by labelers[1].
Q: What factors influence drug prices?
A: Drug prices are influenced by production costs, market demand, regulatory approvals, and competition[4].
Q: How do patent expirations affect drug prices?
A: Patent expirations can lead to a decline in sales for specific drugs as generics enter the market, reducing prices[4].
Q: What is the projected growth rate for the biopharma market?
A: The biopharma market is projected to have a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].
Sources
- FDA's National Drug Code Directory - FDA
- MISSOURI SPECIALTY MAC NAME OF DRUG Strength - Missouri Department of Social Services
- 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
- NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - GlobalData
- National Drug Code Database Background Information - FDA
